![]() |
![]() |
|
|
Forward to a colleague |
||
Access Full Stories Procter & Gamble (P&G) has this week terminated an agreement with Nastech to develop a nasally delivered version of Eli Lilly's osteoporosis drug Forteo (teriparatide), leaving its partner with no explanation... Read Add PEG to make the drug go farther A US research team has found a way to increase drug distribution in the brain to fight the recurrence of human brain tumours... Read Genentech named facility of the year winner US biotechnology company Genentech is filling its trophy cupboard again after being named the winner of the 2007 Facility of the Year Award... Read West unscathed by Exubera shot - for now West Pharmaceutical Services, one of the two firms responsible for manufacturing Pfizer's failed Exubera device, recently turned in its third quarter financials, so far avoiding any major dent from the company's... Read New counterfeit report highlights worrying trends A new report highlights a number of worrying trends emerging in regard to the increasing number of fake pharmaceuticals infiltrating supply chains around the globe... Read |
|||||||||||||||
All News Headlines for: November | October | September |
|||||||||||||||
![]() Oncological API Specialist ScinoPharm, specialized in manufacturing cGMP grade oncological APIs, offers fully integrated services to develop and manufacture final APIs capabilities including process research and development, analytical development and regulatory submission... Click Here | |||||||||||||||
Drugs moving into the clinic: 34 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read 'World's first' NanoImaging service centre opens NanoImaging Services has opened what it claims is a first of its kind first fee-for-service imaging business to enable structural characterisation and validation of biological drugs throughout the development... Read The sweet taste of analysing biological drugs Researchers from Amgen have published results detailing a method that improves the analysis of the sugar groups attached to monoclonal antibodies (MAbs) and proteins... Read CROs link arms to spread reach This week two sets of contract research organisations (CROs) have announced plans to link arms in order to spread their reach further into this increasingly globalised marketplace... Read
|
|||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||